Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Goldfinger N

Collect these papers and discover other ones on Labmeeting. Learn more.

Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer.

+ cite this

+ View Abstract

Paland N, Kamer I, Kogan-Sakin I, Madar S, Goldfinger N, and Rotter V

Molecular cancer research : MCR 7(8):1212-23, 2009 Aug - Who cited this? | PubMed ID: 19671672 | Fulltext

Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1.

+ cite this

+ View Abstract

Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, Brosh R, Buganim Y, Goldfinger N, Klocker H, Schalken JA, and Rotter V

Carcinogenesis 30(4):698-705, 2009 Apr - Who cited this? | PubMed ID: 19233959 | Fulltext

Cancer cells suppress p53 in adjacent fibroblasts.

+ cite this

+ View Abstract

Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovich A, Rechavi G, Rotter V, and Oren M

Oncogene 28(6):933-6, 2009 Feb 12 - Who cited this? | PubMed ID: 19060923 | Fulltext

Modulated expression of WFDC1 during carcinogenesis and cellular senescence.

+ cite this

+ View Abstract

Madar S, Brosh R, Buganim Y, Ezra O, Goldstein I, Solomon H, Kogan I, Goldfinger N, Klocker H, and Rotter V

Carcinogenesis 30(1):20-7, 2009 Jan - Who cited this? | PubMed ID: 18842679 | Fulltext

Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.

+ cite this

+ View Abstract

Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, and Kalland KH

PLoS ONE 4(3):e4687, 2009 - Who cited this? | PubMed ID: 19262738 | Fulltext

Identification of gene networks associated with erythroid differentiation.

+ cite this

+ View Abstract

Peller S, Tabach Y, Rotschild M, Garach-Joshua O, Cohen Y, Goldfinger N, and Rotter V

Blood cells, molecules & diseases 43(1):74-80, 2009 - Who cited this? | PubMed ID: 19329339 | Fulltext

Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation.

+ cite this

+ View Abstract

Ke XS, Qu Y, Goldfinger N, Rostad K, Hovland R, Akslen LA, Rotter V, Oyan AM, and Kalland KH

PLoS ONE 3(10):e3368, 2008 - Who cited this? | PubMed ID: 18852876 | Fulltext

p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

+ cite this

+ View Abstract

Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, and Rotter V

PLoS ONE 3(11):e3707, 2008 - Who cited this? | PubMed ID: 19002260 | Fulltext

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.

+ cite this

+ View Abstract

Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Børresen-Dale AL, Ginsberg D, Harris CC,

(show remaining authors)

Molecular systems biology 4:229, 2008 - Who cited this? | PubMed ID: 19034270 | Fulltext

Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

+ cite this

+ View Abstract

Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, and Rotter V

Molecular and cellular biology 27(23):8228-42, 2007 Dec - Who cited this? | PubMed ID: 17875924 | Fulltext

Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.

+ cite this

+ View Abstract

Tang X, Milyavsky M, Goldfinger N, and Rotter V

Oncogene 26(52):7302-12, 2007 Nov 15 - Who cited this? | PubMed ID: 17533371 | Fulltext

Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension.

+ cite this

+ View Abstract

Efrati S, Berman S, Goldfinger N, Erez N, Averbukh Z, Golik A, Rotter V, and Weissgarten J

Journal of hypertension 25(5):1041-52, 2007 May - Who cited this? | PubMed ID: 17414669 | Fulltext

Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.

+ cite this

+ View Abstract

Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, Eden A,

(show remaining authors)

Cancer cell 11(2):133, 2007 Feb - Who cited this? | PubMed ID: 17292825 | Fulltext

Regulation of AIF expression by p53.

+ cite this

+ View Abstract

Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, and Rotter V

Cell death and differentiation 13(12):2140-9, 2006 Dec - Who cited this? | PubMed ID: 16729031 | Fulltext

Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction.

+ cite this

+ View Abstract

Buganim Y, Kalo E, Brosh R, Besserglick H, Nachmany I, Rais Y, Stambolsky P, Tang X, Milyavsky M, Shats I, Kalis M, Goldfinger N, and Rotter V

Cancer research 66(22):10750-9, 2006 Nov 15 - Who cited this? | PubMed ID: 17108111 | Fulltext

hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

+ cite this

+ View Abstract

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, Klocker H, Wasylyk B, Voller M, Aalders T, Schalken JA, Oren M, and Rotter V

Cancer research 66(7):3531, 2006 Apr 1 - Who cited this? | PubMed ID: 16585177 | Fulltext

Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein.

+ cite this

+ View Abstract

Orgad S, Goldfinger N, Cohen G, Rotter V, and Solomon B

FEBS letters 579(25):5609-15, 2005 Oct 24 - Who cited this? | PubMed ID: 16213502 | Fulltext

Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.

+ cite this

+ View Abstract

Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X, Kalis M, Kogan I, Buganim Y, Goldfinger N, Ginsberg D, Harris CC, Domany E, and Rotter V

Cancer research 65(11):4530-43, 2005 Jun 1 - Who cited this? | PubMed ID: 15930270 | Fulltext

Transactivation of the EGR1 gene contributes to mutant p53 gain of function.

+ cite this

+ View Abstract

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, and Rotter V

Cancer research 64(22):8318-27, 2004 Nov 15 - Who cited this? | PubMed ID: 15548700 | Fulltext

Activated p53 suppresses the histone methyltransferase EZH2 gene.

+ cite this

+ View Abstract

Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, and Rotter V

Oncogene 23(34):5759-69, 2004 Jul 29 - Who cited this? | PubMed ID: 15208672 | Fulltext

p53 is a regulator of macrophage differentiation.

+ cite this

+ View Abstract

Matas D, Milyavsky M, Shats I, Nissim L, Goldfinger N, and Rotter V

Cell death and differentiation 11(4):458-67, 2004 Apr - Who cited this? | PubMed ID: 14713961 | Fulltext

Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.

+ cite this

+ View Abstract

Erez N, Milyavsky M, Eilam R, Shats I, Goldfinger N, and Rotter V

Cancer research 63(24):8777-83, 2003 Dec 15 - Who cited this? | PubMed ID: 14695194 | Fulltext

Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.

+ cite this

+ View Abstract

Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, Meerson A, Tabach Y, Goldfinger N, Ginsberg D, Harris CC, and Rotter V

Cancer research 63(21):7147-57, 2003 Nov 1 - Who cited this? | PubMed ID: 14612508 | Fulltext

The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts.

+ cite this

+ View Abstract

Peller S, Frenkel J, Lapidot T, Kahn J, Rahimi-Levene N, Yona R, Nissim L, Goldfinger N, Sherman DJ, and Rotter V

Oncogene 22(30):4648-55, 2003 Jul 24 - Who cited this? | PubMed ID: 12879009 | Fulltext

Falkor, a novel cell growth regulator isolated by a functional genetic screen.

+ cite this

+ View Abstract

Erez N, Milyavsky M, Goldfinger N, Peles E, Gudkov AV, and Rotter V

Oncogene 21(44):6713-21, 2002 Oct 3 - Who cited this? | PubMed ID: 12360397 | Fulltext

The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA.

+ cite this

+ View Abstract

Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N, and Rotter V

Carcinogenesis 23(6):1025-32, 2002 Jun - Who cited this? | PubMed ID: 12082025 | Fulltext

Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.

+ cite this

+ View Abstract

Lilling G, Nordenberg J, Rotter V, Goldfinger N, Peller S, and Sidi Y

Cancer investigation 20(4):509-17, 2002 - Who cited this? | PubMed ID: 12094546 | Fulltext

Activation of p53 protein by telomeric (TTAGGG)n repeats.

+ cite this

+ View Abstract

Milyavsky M, Mimran A, Senderovich S, Zurer I, Erez N, Shats I, Goldfinger N, Cohen I, and Rotter V

Nucleic acids research 29(24):5207-15, 2001 Dec 15 - Who cited this? | PubMed ID: 11812854 | Fulltext

The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis.

+ cite this

+ View Abstract

Sigal A, Matas D, Almog N, Goldfinger N, and Rotter V

Oncogene 20(35):4891-8, 2001 Aug 9 - Who cited this? | PubMed ID: 11521201 | Fulltext

Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

+ cite this

+ View Abstract

Matas D, Sigal A, Stambolsky P, Milyavsky M, Weisz L, Schwartz D, Goldfinger N, and Rotter V

The EMBO journal 20(15):4163-72, 2001 Aug 1 - Who cited this? | PubMed ID: 11483519 | Fulltext

The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop.

+ cite this

+ View Abstract

Almog N, Milyavsky M, Stambolsky P, Falcovitz A, Goldfinger N, and Rotter V

Carcinogenesis 22(5):779-85, 2001 May - Who cited this? | PubMed ID: 11323398 | Fulltext

Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

+ cite this

+ View Abstract

Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I, Shohat G, Goldfinger N, and Rotter V

Molecular and cellular biology 21(5):1552-64, 2001 Mar - Who cited this? | PubMed ID: 11238892 | Fulltext

p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.

+ cite this

+ View Abstract

Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyavsky M, Goldfinger N, and Rotter V

Cancer research 61(1):88-96, 2001 Jan 1 - Who cited this? | PubMed ID: 11196204 | Fulltext

p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53.

+ cite this

+ View Abstract

Almog N, Goldfinger N, and Rotter V

Oncogene 19(30):3395-403, 2000 Jul 13 - Who cited this? | PubMed ID: 10918596 | Fulltext

Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult.

+ cite this

+ View Abstract

Uberti D, Schwartz D, Almog N, Goldfinger N, Harmelin A, Memo M, and Rotter V

Experimental cell research 252(1):123-33, 1999 Oct 10 - Who cited this? | PubMed ID: 10502405 | Fulltext

p53 controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis.

+ cite this

+ View Abstract

Schwartz D, Goldfinger N, Kam Z, and Rotter V

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 10(10):665-75, 1999 Oct - Who cited this? | PubMed ID: 10547070 | Fulltext

Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress.

+ cite this

+ View Abstract

Frenkel J, Sherman D, Fein A, Schwartz D, Almog N, Kapon A, Goldfinger N, and Rotter V

Oncogene 18(18):2901-7, 1999 May 6 - Who cited this? | PubMed ID: 10362261 | Fulltext

Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin.

+ cite this

+ View Abstract

Uberti D, Yavin E, Gil S, Ayasola KR, Goldfinger N, and Rotter V

Brain research. Molecular brain research 65(2):167-75, 1999 Mar 5 - Who cited this? | PubMed ID: 10064887 | Fulltext

Mutant p53 protein expression interferes with p53-independent apoptotic pathways.

+ cite this

+ View Abstract

Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, and Rotter V

Oncogene 16(25):3269-77, 1998 Jun 25 - Who cited this? | PubMed ID: 9681825 | Fulltext

P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrations.

+ cite this

+ View Abstract

Prokocimer M, Peller S, Ben-Bassat H, Goldfinger N, and Rotter V

Leukemia & lymphoma 29(5-6):607-11, 1998 May - Who cited this? | PubMed ID: 9643574 | Fulltext

Molecular alterations in the TP53 gene of peripheral blood cells of patients with chronic myeloid leukemia.

+ cite this

+ View Abstract

Peller S, Yona R, Kopilova Y, Prokocimer M, Goldfinger N, Uysal A, Karabulut HG, Tukun A, Bokesoy I, Tuncman G, and Rotter V

Genes, chromosomes & cancer 21(1):2-7, 1998 Jan - Who cited this? | PubMed ID: 9443036 | Fulltext

Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair.

+ cite this

+ View Abstract

Schwartz D, Almog N, Peled A, Goldfinger N, and Rotter V

Oncogene 15(21):2597-607, 1997 Nov 20 - Who cited this? | PubMed ID: 9399647 | Fulltext

Differential expression of the regularly spliced wild-type p53 and its COOH-terminal alternatively spliced form during epidermal differentiation.

+ cite this

+ View Abstract

Rehberger PA, Richter KH, Schwartz D, Goldfinger N, Oskato R, Almog N, Marks F, and Rotter V

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 8(8):851-60, 1997 Aug - Who cited this? | PubMed ID: 9269894 | Fulltext

Anti-p53 autoantibodies in colon cancer patients.

+ cite this

Sthoeger Z, Evron E, Goland S, Shani A, Wolkowicz R, Goldfinger N, Rotter V, and Fogel M

Annals of the New York Academy of Sciences 815:496-8, 1997 Apr 5 - Who cited this? | PubMed ID: 9186708 | Fulltext

The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

+ cite this

+ View Abstract

Almog N, Li R, Peled A, Schwartz D, Wolkowicz R, Goldfinger N, Pei H, and Rotter V

Molecular and cellular biology 17(2):713-22, 1997 Feb - Who cited this? | PubMed ID: 9001225 | Fulltext

Induction of apoptosis and p53 expression in immature thymocytes by direct interaction with thymic epithelial cells.

+ cite this

+ View Abstract

Schreiber L, Sharabi Y, Schwartz D, Goldfinger N, Brodie C, Rotter V, and Shoham J

Scandinavian journal of immunology 44(4):314-22, 1996 Oct - Who cited this? | PubMed ID: 8845023 | Fulltext

Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.

+ cite this

+ View Abstract

Ronen D, Schwartz D, Teitz Y, Goldfinger N, and Rotter V

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 7(1):21-30, 1996 Jan - Who cited this? | PubMed ID: 8788030 | Fulltext

Spot-1, a novel NLS-binding protein that interacts with p53 through a domain encoded by p(CA)n repeats.

+ cite this

+ View Abstract

Elkind NB, Goldfinger N, and Rotter V

Oncogene 11(5):841-51, 1995 Sep 7 - Who cited this? | PubMed ID: 7675445 | Fulltext

Does wild-type p53 play a role in normal cell differentiation?.

+ cite this

+ View Abstract

Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A, and Goldfinger N

Seminars in cancer biology 5(3):229-36, 1994 Jun - Who cited this? | PubMed ID: 7948951 | Fulltext

Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.

+ cite this

+ View Abstract

Aloni-Grinstein R, Zan-Bar I, Alboum I, Goldfinger N, and Rotter V

Oncogene 8(12):3297-305, 1993 Dec - Who cited this? | PubMed ID: 8247532 | Fulltext

Search Google Scholar for Goldfinger N

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!